Application of Theranostics to Measure and Treat Cell Heterogeneity in Cancer

作者: Sophie A. Lelièvre , Kurt B. Hodges , Pierre-Alexandre Vidi

DOI: 10.1016/B978-0-12-407722-5.00026-8

关键词: Identification (biology)CellBiologyStem cellEpigenomicsAnticipation (genetics)Biomarker (cell)CancerGenomicsBioinformatics

摘要: Individualized therapy is a noble anticipation in oncology. It would permit not only to adapt treatment an individual’s physiology and characteristics, but also pinpoint therapeutic features for each neoplasia. The high degree of cell heterogeneity cancer, with mixtures cells different origins populations that evolve toward multiple genomic epigenomic profiles, makes the precise targeting abnormal priority. phenotypic nature cancer largely determined by changes gene transcription requiring identification increasing number intracellular even intranuclear markers. Such requirement brings new challenges state-of-the-art technology focusing on single-cell analysis begs development nanotools can provide multiplex approach necessary target locations reach, detect, appropriately treat subgroups cells. In this chapter we introduce reader discuss how emerging knowledge has shed light difficulties encountered management neoplasias over past few decades. Our illustrates nanotheranostics might help effectively address issue halt progression, overcome resistance treatment, possibly decrease risks among individuals.

参考文章(116)
Swadeshmukul Santra, Fluorescent silica nanoparticles for cancer imaging. Methods of Molecular Biology. ,vol. 624, pp. 151- 162 ,(2010) , 10.1007/978-1-60761-609-2_10
S. Sell, H. A. Dunsford, Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. American Journal of Pathology. ,vol. 134, pp. 1347- 1363 ,(1989)
J. Rüschoff, T. Bocker, P. Vogel, J. Schlegel, Prognostic significance of molecular biological and immunohistological parameters in gastrointestinal carcinomas. Recent results in cancer research. ,vol. 142, pp. 73- 88 ,(1996) , 10.1007/978-3-642-80035-1_6
A. Llombart-Bosch, A. Peydro, Malignant mixed osteogenic tumours of the breast. An ultrastructural study of two cases. Virchows Archiv. ,vol. 366, pp. 1- 14 ,(1975) , 10.1007/BF00438674
Timo Zimmermann, Spectral Imaging and Linear Unmixing in Light Microscopy Advances in Biochemical Engineering \/ Biotechnology. ,vol. 95, pp. 245- 265 ,(2005) , 10.1007/B102216
C. Darrell Jennings, Kenneth A. Foon, Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy Blood. ,vol. 90, pp. 2863- 2892 ,(1997) , 10.1182/BLOOD.V90.8.2863
Laurent Perreard, Cheng Fan, John F Quackenbush, Michael Mullins, Nicholas P Gauthier, Edward Nelson, Mary Mone, Heidi Hansen, Saundra S Buys, Karen Rasmussen, Alejandra Ruiz Orrico, Donna Dreher, Rhonda Walters, Joel Parker, Zhiyuan Hu, Xiaping He, Juan P Palazzo, Olufunmilayo I Olopade, Aniko Szabo, Charles M Perou, Philip S Bernard, Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay Breast Cancer Research. ,vol. 8, pp. 1- 11 ,(2006) , 10.1186/BCR1399